Tamin Pharmaceutical Investment Company (TIPIKO) income statement
Operating revenue through to net profit and earnings per share
- Ticker
- TIPIKO
- Industry
- Pharmaceuticals
- Market
- Tehran Stock Exchange
Latest periods
| Item | To 1405/05/31 | To 1404/05/31 | To 1403/05/31 | To 1402/05/31 | To 1401/05/31 |
|---|---|---|---|---|---|
| سود (زیان) فروش سرمایه گذاری ها | 153,264 | 15,862 | 2,895,229 | 0 | 0 |
| Total operating revenue | 153,264 | 15,862 | 2,895,229 | 210,273 | 129,874 |
| هزینه های حقوق، دستمزد و مزایا | -398,291 | -308,245 | -304,893 | -151,828 | -83,274 |
| Depreciation expense | -7,030 | -5,429 | - | - | - |
| Other expenses | -83,055 | -27,472 | 0 | 0 | 0 |
| جمع هزینه های عملیاتی | -488,376 | -341,146 | -304,893 | -151,828 | -83,274 |
| Operating profit (loss) | -335,112 | -325,284 | 2,590,336 | 58,445 | 46,600 |
| Other non-operating income and expenses | -154,429 | -23 | 7,452 | 7,450 | 33,780 |
| Profit (loss) from continuing operations before tax | -489,541 | -325,307 | 2,597,788 | 65,895 | 80,380 |
| Net profit (loss) from continuing operations | -489,541 | -325,307 | 2,597,788 | 65,895 | 80,380 |
| Net profit (loss) | -489,541 | -325,307 | 2,597,788 | 65,895 | 80,380 |
| Operating (rials) | -10 | -30 | 235 | 5 | 4 |
| Non-operating (rials) | -5 | 0 | 1 | 1 | 3 |
| Arising from continuing operations | -15 | -30 | - | - | - |
| سود (زیان) پایه هر سهم (ریال) | -15 rials | -30 rials | 236 rials | 6 rials | 7 rials |
| سود (زیان) خالص هر سهم (ریال) | -15 rials | -29 rials | 237 rials | 6 rials | 8 rials |
| Capital | 32,000,000 | 11,000,000 | 11,000,000 | 11,000,000 | 11,000,000 |
Reporting periods
36 periods are on file for this report, from the period ending 1392/02/31 to the period ending 1405/07/07.